HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Daniel Putzer Selected Research
Daniel Putzer Research Topics
Disease
22
Neoplasms (Cancer)
01/2022 - 08/2009
9
Neoplasm Metastasis (Metastasis)
09/2021 - 08/2009
5
Hepatocellular Carcinoma (Hepatoma)
05/2020 - 01/2018
4
Glioma (Gliomas)
01/2014 - 11/2011
3
Breast Neoplasms (Breast Cancer)
09/2021 - 09/2019
3
Thyroid Neoplasms (Thyroid Cancer)
12/2015 - 06/2012
2
Cholangiocarcinoma
01/2022 - 05/2020
2
Carcinoma (Carcinomatosis)
10/2013 - 08/2012
2
Hyperparathyroidism
01/2010 - 09/2008
2
Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2009 - 08/2009
1
Fibrosis (Cirrhosis)
04/2022
1
Inflammation (Inflammations)
04/2022
1
Liver Diseases (Liver Disease)
04/2022
1
Liver Cell Adenoma (Hepatocellular Adenoma)
01/2022
1
Pneumothorax
05/2021
1
Hemorrhage
05/2021
1
Chronic Disease (Chronic Diseases)
05/2020
1
Hypotension (Low Blood Pressure)
01/2018
1
Tick-Borne Encephalitis (Encephalitis, Tick Borne)
10/2016
1
Colorectal Neoplasms (Colorectal Cancer)
03/2014
1
Squamous Cell Carcinoma of Head and Neck
09/2013
1
Brain Neoplasms (Brain Tumor)
03/2013
1
Prostatic Neoplasms (Prostate Cancer)
08/2012
1
Leukemia
04/2012
1
Pain (Aches)
07/2011
1
Hyperalgesia
07/2011
1
Secondary Hyperparathyroidism
11/2009
1
Primary Hyperparathyroidism
09/2008
Drug/Important Bio-Agent (IBA)
2
Glucose (Dextrose)
FDA Link
Generic
10/2016 - 12/2015
2
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
IBA
12/2015 - 09/2009
2
Octreotide (Sandostatin)
FDA Link
Generic
12/2015 - 09/2013
2
Somatostatin Receptors (Somatostatin Receptor)
IBA
12/2015 - 08/2009
2
Somatostatin (Somatotropin Release-Inhibiting Factor)
IBA
04/2014 - 08/2009
2
Radioisotopes (Radionuclides)
IBA
10/2013 - 09/2009
2
Tyrosine (L-Tyrosine)
FDA Link
07/2013 - 03/2013
1
NADPH Oxidase 4
IBA
04/2022
1
Interleukin-11 (Interleukin 11)
IBA
04/2022
1
Ethanol (Ethyl Alcohol)
IBA
04/2022
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
04/2022
1
JNK Mitogen-Activated Protein Kinases
IBA
04/2022
1
Capsules (Microcapsules)
IBA
01/2022
1
Hormones (Hormone)
IBA
08/2021
1
Anesthetics (Anesthetic Agents)
IBA
05/2021
1
Sirtuins
IBA
09/2019
1
iopromide (Ultravist)
FDA Link
01/2018
1
iodixanol (Visipaque)
FDA Link
01/2018
1
Ligands
IBA
12/2015
1
lanreotide (Somatuline)
FDA Link
12/2015
1
Immunomodulating Agents
IBA
03/2014
1
Lenalidomide (CC 5013)
FDA Link
03/2014
1
Nucleosides
IBA
01/2014
1
Amino Acids
FDA Link
01/2014
1
alovudine
IBA
01/2014
1
Cisplatin (Platino)
FDA Link
Generic
10/2013
1
Gemcitabine
FDA Link
10/2013
1
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
10/2013
1
Peptide Receptors (Peptide Receptor)
IBA
10/2013
1
Edotreotide (SMT 487)
IBA
09/2013
1
Androgen Antagonists (Antiandrogens)
IBA
08/2012
1
Choline (Choline Chloride)
IBA
08/2012
1
Bortezomib (Velcade)
FDA Link
06/2012
1
Proteasome Inhibitors
IBA
06/2012
1
Glycoproteins (Glycoprotein)
IBA
11/2011
1
Peptides (Polypeptides)
IBA
11/2011
1
Biological Products
IBA
11/2011
1
Radiopharmaceuticals
IBA
11/2011
1
Parathyroid Hormone (Parathormone)
IBA
09/2008
Therapy/Procedure
23
Radiofrequency Ablation
01/2022 - 01/2019
7
Therapeutics
09/2019 - 09/2009
1
Palliative Care (Palliative Therapy)
01/2022
1
Chest Tubes (Chest Tube)
05/2021
1
Ablation Techniques
10/2019
1
Radiotherapy
09/2019
1
Intravenous Administration
01/2018
1
Liver Transplantation
01/2018
1
Drug Therapy (Chemotherapy)
10/2013
1
Prostatectomy (Retropubic Prostatectomy)
08/2012
1
Radioimmunotherapy
04/2012
1
Stem Cell Transplantation
04/2012
1
Electrodes (Electrode)
07/2011
1
Minimally Invasive Surgical Procedures
01/2010
1
Kidney Transplantation
11/2009
1
Thyroidectomy
09/2008